StockMarketWire.com - Life sciences company OptiBiotix Health has announced that subsidiary ProBiotix Health has struck a distribution agreement with Ayalla Marketing.
The deal will boost distribution in Brazil of ProBiotix's cholesterol reducing probiotic LPLDL as both an ingredient and as four finished products (CholBiome, CholBiomeX3, CholBiomeBP and CholBiomeVH).
The agreement is for an initial period of 12 months and has "modest" minimum order quantities for each product, OptiBiotix said, providing it with security of income and revenue growth.
LPLDL aids cardiovascular health through a plant-based alternative to statins.
At 9:56am: [LON:OPTI] Optibiotix Health Plc share price was +0.5p at 54p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.